Adagene
ADAG
17 hedge funds and large institutions have $6.03M invested in Adagene in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 4 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0% more funds holding
Funds holding: 17 → 17 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
5.59% less ownership
Funds ownership: 12.14% → 6.56% (-5.6%)
46% less capital invested
Capital invested by funds: $11.3M → $6.03M (-$5.22M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Exome Asset Management
New York
|
+$1.96M |
| 2 |
FLC
Fifth Lane Capital
Austin,
Texas
|
+$217K |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
+$33.2K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$14.5K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$2.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GA
General Atlantic
New York
|
-$7.53M |
| 2 |
GCS
Gordian Capital (Singapore)
Singapore
|
-$96.2K |
| 3 |
MG
Marex Group
London,
|
-$46.6K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$21.5K |
| 5 |
Morgan Stanley
New York
|
-$13.1K |
ADAG Hedge Fund Activity: Q4 2025 in Review
17 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in Adagene (ADAG) for Q4 2025, worth a combined $6.03M — down 46% from $11.3M a quarter earlier.
Fund positioning in ADAG was balanced in Q4 2025: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 3 trimmed.
The largest buyer was Exome Asset Management, opening a new position worth an estimated $1.96M. The largest seller was General Atlantic, exiting entirely with an estimated $7.53M sold.
- 17 institutional investors held Adagene (ADAG) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $6.03M of Adagene stock for Q4 2025, down 46% quarter-over-quarter.
- 4 funds opened new Adagene positions in Q4 2025 and 4 closed out, a net change of 0 holders.
- The largest Adagene buyer in Q4 2025 was Exome Asset Management, an estimated $1.96M added.
- The largest Adagene seller in Q4 2025 was General Atlantic, an estimated $7.53M sold.
Based on aggregated 13F filings for Q4 2025.